BRIEF published on 01/31/2025 at 15:05, 10 months 4 days ago 1933 Industries Appoints New CFO and VP Finance CFO Appointment Cannabis Industry Financial Strategy 1933 Industries VP Finance
PRESS RELEASE published on 01/31/2025 at 15:00, 10 months 4 days ago 1933 Industries Appoints New CFO and VP Finance 1933 Industries Inc. announces Jeremy Fong as CFO and Kathy Estochin as VP Finance & Administration. Mr. Fong brings auditing and financial expertise. Ms. Estochin has 35 years of accounting experience CFO 1933 Industries Inc. VP Finance Jeremy Fong Kathy Estochin
BRIEF published on 01/24/2025 at 23:35, 10 months 11 days ago 1933 Industries Faces Delay in Filing Financial Statements Financial Statements Cease Trade Order Cannabis Market Filing Delay 1933 Industries
PRESS RELEASE published on 01/24/2025 at 23:30, 10 months 11 days ago 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report 1933 Industries Inc. provides an update on the management cease trade order due to late financial filings. Expecting to complete audited filings in February 2025 Market Position Financial Report Management Cease Trade Order 1933 Industries Audited Filings
BRIEF published on 01/10/2025 at 23:05, 10 months 25 days ago 1933 Industries Updates on Delayed Filing and Management Transition CEO Transition Filing Delay 1933 Industries Financial Update Nevada Cannabis
PRESS RELEASE published on 01/10/2025 at 23:00, 10 months 25 days ago 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes 1933 Industries Inc. provides an update on the status of its audited financial statements and appoints a new Interim CEO following the resignation of Mr. Paul Rosen Interim CEO Cannabis Cultivator Financial Statements Management Cease Trade Order 1933 Industries
BRIEF published on 12/27/2024 at 15:05, 11 months 8 days ago 1933 Industries Updates on Filing Delay for Quarterly Report Financial Statements Cannabis Industry MCTO Filing Delay 1933 Industries
PRESS RELEASE published on 12/27/2024 at 15:00, 11 months 8 days ago 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report 1933 Industries Inc. provides update on management cease trade order for late filing of audited financial statements. Expectation of filings by January 27, 2025 Management Cease Trade Order MCTO 1933 Industries Inc. Audited Financial Statements Nevada Cannabis Cultivator
BRIEF published on 12/13/2024 at 15:05, 11 months 22 days ago 1933 Industries Updates on Filing Delay and Achievements Cannabis Industry 1933 Industries Nevada Market Financial Delay LeafLink Award
PRESS RELEASE published on 12/13/2024 at 15:00, 11 months 22 days ago 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report 1933 Industries Inc. provides update on management cease trade order and filing delay. Company's flagship brand, Alternative Medicine Association, wins LeafLink List 2024 award for Top Selling in Nevada Management Cease Trade Order Filing Delay 1933 Industries Inc. Alternative Medicine Association LeafLink List 2024 Award
Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025